52 Biggest Movers From Yesterday

Gainers

• Capricor Therapeutics Inc CAPR shares gained 93.5% to close at $6.23 on Monday after the company announced its interim analysis in the HOPE-2 trial to treat patients with duchenne muscular dystrophy showed statistically significant results.
• Carolina Trust BancShares, Inc. CART rose 32.3% to close at $10.13. Carolina Financial Corporation CARO announced plans to acquire Carolina Trust BancShares.
• Chicken Soup for the Soul Entertainment, Inc. CSSE rose 19.7% to close at $8.40.
• CannTrust Holdings Inc. CTST gained 18.6% to close at $3.06.
• Mereo BioPharma Group plc MREO rose 18.5% to close at $2.63 after the company reported successful Type B meeting with the FDA and outlines accelerated approval pathway for navicixizumab in advanced ovarian cancer.
• Galapagos NV GLPG shares climbed 17.2% to close at $170.76 after the company announced it has entered into a research and development collaboration with Gilead Sciences, Inc. GILD. Gilead said it will make a $3.95-billion upfront payment and $1.1-billion equity investment in the Belgian pharmaceutical company, according to a Sunday press release. Galapagos intends to use the proceeds to expand its research and development programs.
• Avrobio Inc AVRO gained 15% to close at $16.42 after the company announced data from two ongoing clinical trials of AVR RD 01 in Fabry disease, which showed an 87% substrate reduction in first kidney biopsy.
• CEL-SCI Corporation CVM surged 14% to close at $6.84.
• Perion Network Ltd. PERI gained 13.6% to close at $4.00.
• AquaBounty Technologies, Inc. AQB gained 12.9% to close at $3.93.
• Golden Star Resources Ltd. GSS gained 12.5% to close at $4.76.
• Caladrius Biosciences Inc CLBS rose 11.8% to close at $2.94 after the company received advanced therapy medicinal product classification for CLBS12, its CD34+ cell therapy for critical limb ischemia.
• Workhorse Group Inc. WKHS surged 11.5% to close at $3.89.
• Barnes & Noble Education, Inc. BNED gained 11.2% to close at $3.96. Barnes & Noble Education's board confirmed it rejected Bay Finance's $4.50 per share acquisition offer along with other non-credible offers.
• Xcel Brands, Inc. XELB gained 11.1% to close at $3.50.
• Zovio Inc ZVO rose 10.4% to close at $4.02 after announcing approval by WSCUC for Ashford University to become an independent and nonprofit institution.
• Curis, Inc. CRIS jumped 9.3% to close at $2.46.
• The Peck Company, Inc. PECK gained 9.3% to close at $6.60.
• AGM Group Holdings Inc. AGMH gained 9.2% to close at $17.65.
• Oasmia Pharmaceutical AB OASM rose 8.9% to close at $2.32 after climbing 18.99% on Friday.
• Omnicell, Inc. OMCL rose 8.2% to close at $74.23 after the company reported formalized long-term partnership with Northern Arizona Healthcare to digitize and automate medication mgmt. processes.
• Biohaven Pharmaceutical Holding Company Ltd. BHVN gained 7.5% to close at $45.72 after a publication of Phase 3 results for the company's migraine medicine, Zydis, was released. The drug demonstrated superiority against a placebo.
• Neon Therapeutics, Inc. NTGN rose 6.9% to close at $4.62 after the company announced its personal neoantigen vaccine study demonstrated prolonged progression-free survival in advance or metastatic melanoma, non-small cell lung and bladder cancers.
• Cara Therapeutics, Inc. CARA rose 4.7% to close at $25.42.

Losers

• Yogaworks Inc YOGA shares tumbled 26.2% to close at $0.48 on Monday after the company announced it will delist its shares from Nasdaq.
• ShiftPixy Inc PIXY fell 18.2% to close at $0.60 after the company postponed its Q3 earnings to an undisclosed date.
• Callon Petroleum Company CPE shares fell 15.9% to close at $5.38. Carrizo agreed to be acquired by Callon Petroleum in an all-stock deal.
• Eton Pharmaceuticals Inc ETON shares fell 15.7% to close at $7.00 after the FDA sent a Complete Response Letter to the company for EM-100.
• NeuBase Therapeutics, Inc. NBSE fell 15.6% to close at $4.55.
• Syros Pharmaceuticals, Inc. SYRS dipped 14.1% to close at $7.52.
• Soliton, Inc. SOLY fell 13.5% to close at $16.05. Soliton announced 26-week cellulite clinical trial results demonstrating long-term improvement.
• Xenetic Biosciences, Inc. XBIO dipped 13.3% to close at $10.97.
• CIRCOR International, Inc. CIR fell 12.6% to close at $36.97. Crane Co. CR disclosed that it will not extend its offer to acquire CIRCOR for $48 per share beyond July 19th.
• Organogenesis Holdings Inc. ORGO dipped 11.9% to close at $6.82.
• Jaguar Health, Inc. JAGX tumbled 11.9% to close at $2.82.
• Vuzix Corporation VUZI fell 11.5% to close at $2.55.
• Eros International Plc EROS shares fell 11.5% to close at $1.61 following downbeat Q4 sales.
• China Lending Corporation CLDC rose 11.4% to close at $1.03 after the company announced it will enter into a 5-year partnership with Rui Xin Insurance Technology to develop an online financial services platform.
• Symantec Corporation SYMC dropped 10.7% to close at $22.84 after CNBC reported the company and Broadcom have ceased deal negotiations.
• Hi-Crush Inc. HCR dropped 10.3% to close at $2.09.
• Five9, Inc. FIVN fell 10.2% to close at $48.04.
• Party City Holdco Inc. PRTY fell 10.1% to close at $6.39.
• Zynex, Inc. ZYXI dropped 10.1% to close at $7.70.
• Centennial Resource Development, Inc. CDEV fell 9.7% to close at $6.89 after Jeffries downgraded the stock from Buy to Hold.
• ShotSpotter, Inc. SSTI dropped 9.5% to close at $39.09 after Northland downgraded the stock from Outperform to Market Perform and lowered its price target from $60 to $47 per share.
• Overstock.com, Inc. OSTK dipped 9.4% to close at $17.22.
• HOOKIPA Pharma Inc. HOOK fell 9.3% to close at $7.45 on Monday after climbing 22.90% on Friday.
• So-Young International Inc. SY dropped 9.1% to close at $15.25 after rising 3.20% on Friday.
• PG&E Corporation PCG fell 8.6% to close at $17.74, potentially tied to CA Governor Newsom's recent comments showing opposition to the company being able to securitize wildfire liabilities from 2017 and 2018 wildfires.
• Teva Pharmaceutical Industries Limited TEVA fell 7.5% to close at $8.56. Morgan Stanley downgraded Teva from Equal-Weight to Underweight and lowered the price target from $16 to $6.
• Micro Focus International plc MFGP fell 6.1% to close at $20.67.
• Dova Pharmaceuticals, Inc. DOVA fell 5.5% to close at $16.06.